This study examined whether mindfulness-based stress reduction (MBSR) is noninferior to cognitive behavioral therapy for insomnia (CBT-I) for the treatment of insomnia in patients with cancer. Participants were recruited from a tertiary cancer center in Calgary, Alberta, Canada, from 2008 to 2011. Assessments were conducted at baseline, after the program, and after 3 months of follow-up. This study found that lthough MBSR produced a clinically significant change in sleep and psychological outcomes, CBT-I was associated with rapid and durable improvement and remains the best choice for the nonpharmacologic treatment of insomnia.
Primary Investigator:
Sheila N Garland, PhD (Abramson Cancer Center, University of Pennsylvania Health System, and Perelman School of Medicine)
Co-Investigators:
Linda E Carlson, PhD (University of Calgary, Calgary, Alberta, Canada)
Alisa J Stephens, PhD (Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA)
Michael C Antle, PhD (University of Calgary, Calgary, Alberta, Canada)
Charles Samuels, MD (University of Calgary, Calgary, Alberta, Canada)
Tavis S Campbell, PhD (University of Calgary, Calgary, Alberta, Canada)